These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12496449)

  • 21. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
    J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis.
    Deng C; Wu B; Yang H; Hussain RZ; Lovett-Racke AE; Christadoss P; Racke MK
    J Neuroimmunol; 2003 May; 138(1-2):76-82. PubMed ID: 12742656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor.
    Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
    J Neuroimmunol; 1999 Mar; 95(1-2):73-84. PubMed ID: 10229117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.
    Karachunski PI; Ostlie N; Conti-Tronconi BM; Bellone M
    Immunology; 1994 May; 82(1):22-7. PubMed ID: 7519170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.
    Oshima M; Deitiker P; Ashizawa T; Atassi MZ
    Autoimmunity; 2002 May; 35(3):183-90. PubMed ID: 12389643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB; Shi FD; Li H; Chambers BJ; Link H; Ljunggren HG
    J Immunol; 2001 May; 166(10):6430-6. PubMed ID: 11342669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses.
    Oshima M; Atassi MZ
    Autoimmunity; 2000; 32(1):45-55. PubMed ID: 10958175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1.
    Yang H; Tüzün E; Alagappan D; Yu X; Scott BG; Ischenko A; Christadoss P
    J Immunol; 2005 Aug; 175(3):2018-25. PubMed ID: 16034147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.
    Poussin MA; Goluszko E; Hughes TK; Duchicella SI; Christadoss P
    J Neuroimmunol; 2000 Nov; 111(1-2):152-60. PubMed ID: 11063833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
    Bellone M; Ostlie N; Karachunski P; Manfredi AA; Conti-Tronconi BM
    J Immunol; 1993 Jul; 151(2):1025-38. PubMed ID: 7687612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis.
    Karachunski PI; Ostlie NS; Okita DK; Garman R; Conti-Fine BM
    J Neuroimmunol; 1999 Jan; 93(1-2):108-21. PubMed ID: 10378874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes.
    Monfardini C; Milani M; Ostlie N; Wang W; Karachunski PI; Okita DK; Lindstrom J; Conti-Fine BM
    J Neuroimmunol; 2002 Feb; 123(1-2):123-34. PubMed ID: 11880157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL; Zborowski KA; Kraig E; Infante AJ
    Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.